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Continuous proliferation  of T  cells after stimulation  with  antigens or mitogens is 
maintained  by growth factors, released  by lectin- or antigen-activated  T  cells  (1-3). 
T  cell growth factor (TCGF) supports only the growth of activated, but not of resting, 
T  ceils  (2-3).  However,  resting T  cells  become sensitive  to TCGF  when  they have 
been activated  by HLA-DR  antigens. 1' z This  initial  event  in T  cell  triggering does 
not by itself result in growth or proliferation, because proliferation necessarily requires 
the presence of TCGF  (2-3). l'z Once TCGF  has  been  produced  and  the  resting T 
cells have been rendered  sensitive  to it, there is no further requirement  for antigen, 
lectin,  or HLA-DR-positive  accessory cells,  and  the  concentration  of TCGF  is  the 
only variable determining the extent of proliferation of the TCGF-reactive T  cells (2- 
3).1, 2 
Concanavalin  A  (Con-A)-induced suppressor  cell  function  has been shown  to be 
caused by T  cells  (4).  We have investigated  (a) whether Con-A-activated suppressor 
T  cells respond to TCGF stimulation and (b) whether these cells cause suppression by 
decreasing  the availability  of TCGF  produced  by the  responding  cells.  The results 
indicate that Con-A-activated suppressor T  cells are sensitive to TCGF and that one 
mechanism by which these suppressor cells exert suppression  is by absorbing TCGF, 
thereby decreasing the concentration of obligatory growth factors. 
Materials  and Methods 
Cell Separation.  Peripheral blood mononuclear cells  (MNC)  from healthy adult volunteers 
were obtained  as previously described  (5). T  cells  were obtained  by passing MNC through 
nylon wool columns as described elsewhere (6). The cells eluted from nylon fiber columns were 
washed  and  resuspended  in  RPMI-1640  medium  (Grand  Island  Biological  Co.,  Europe, 
Glasgow, Scotland)  supplemented  with  10%  heat-inactivated  fetal  calf serum,  20 ~g/ml  of 
gentamicin, 2 mM of glutamine, and  1% Hepes buffer solution (Grand Island Biological Co., 
Europe), which will be referred to as complete culture medium  (CCM). To obtain adherent 
cells,  MNC suspended in CCM were incubated at  37°C for 120 min in plastic petri  dishes. 
Nonadherent ceils were removed by three washings and the adherent cells were obtained by 
removing them from the plastic surface with a rubber policeman. 
TCGF Production.  We have used two different methods for obtaining TCGF.  In the first, 
TCGF  was  obtained  from  phytohemagglutinin  (PHA)-stimulated  MNC  as  described  by 
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Bonnard  et  al.  (7).  In  the  second  method,  TCGF  was  obtained  from  autologous  mixed 
lymphocyte cultures, by coculturing 3 ×  106 T  cells with 3 ×  106 irradiated autologous non-T 
cells in 1.5 ml of CCM in 17- ×  100-mm round-bottomed plastic tubes (Falcon Labware, Div. 
of Becton, Dickinson & Co., Oxnard, Calif.). After 48 h of incubation at 37°C, the tubes were 
centrifuged at 2,000 rpm for 15 rain, the supemates collected, filtered through 0.45-/tm filters 
(Millipore, S.A., France) and stored at -20°C until used. Those supematant media that only 
induced proliferation of activated T  cells, but not of resting T  cells, were considered to possess 
TCGF activity. 
Generation of Suppressor Cells with Con-A.  3 X  106 T  cells supplemented with 3% of irradiated 
adherent cells were either treated with 20 #g/ml of Con-A (Con-A-activated T  cells) or left 
untreated (nonactivated T  cells) at 37°C for 48 h. The cells were harvested and washed three 
times  in  CCM.  A  portion  of the  cells were  treated  with  mitomycin C  (45  /xg/ml,  Sigma 
Chemical  Co.,  St.  Louis,  Mo.)  at  37°C  for  30  min  and  tested  for  suppressor  activity on 
proliferative responses (see below). 
Two assay systems were used to detect suppressor activity. In the first,  105 mitomycin C- 
treated, Con-A-activated T  cells or their controls were cocultured with 105 responding cells in 
flat-bottomed microtiter plates (Nunclon Delta; A/S Nunc, Copenhagen, Denmark). PHA (1 
#g/ml) or 10  n irradiated (2,500 rad) allogeneie MNC were added in each well in a vol of 0.1 ml 
of CCM. TCGF or medium was placed in each well at concentrations with final dilutions of 
1:2 and 1:4, and were added at different time periods after the initiation ofcuhures. Proliferation 
of the responding MNC was measured by the incorporation of [SH]thymidine (0.5 #Ci/well, 
The Radiochemieal Centre, Amersham, England) during the last 18 h of 4-d culture for PHA- 
induced  cell  proliferation and  a  6-d  culture  for  the  mixed  leukocyte reaction  (MLR)  as 
previously described (5). In the second assay system, inhibition of immunoglobulin production 
6  was measured. 10  responding MNC suspended in CCM containing pokeweed mitogen (PWM) 
(20 #g/ml) were cocultured with 10  n Con-A-activated T cells or control cells in the presence or 
absence of TCGF (final dilutions 1:2 and  1:4). Each culture was carried out in  12- ×  75-mm 
round-bottomed plastic tubes and incubated at 37°C in a humidified atmosphere of 5% CO2 
in air for 7 d. The number of immunoglobulin-secreting cells (PFC) was determined with a 
reverse hemolytic plaque assay as described by Gronowicz et al. (8). We also did experiments 
in which Cyclosporin-A (CYA) was added into plastic tubes containing T  cells suspended in 
CCM in the presence of Con-A. After 48 h of incubation at 37°C, the ceils were washed four 
times and resuspended in CCM.  CYA-treated or untreated T  cells were added to a  second 
culture to test their suppressor activity on both PHA and alloantigen-induced DNA synthesis 
and PWM-driven immunoglobulin production. We also studied whether CYA-treated T  cells 
were sensitive to TCGF and whether they were able to absorb the growth factor as described 
before. The degree of inhibition was calculated according to the following formula: 
percent  suppression ---- 1 _  (~._~)A  -  B  X  100, where A  is the counts  per minute or PFC in 
stimulated cultures containing Con-A-activated cells; B  is the counts per minute or PFC in 
nonstimulated cultures containing Con-A-activated cells; C is the counts per minute or PFC in 
stimulated responding cells; and D is the counts per minute or PFC in nonstimulated responding 
cells. 
Results 
TCGF Abrogates Con-A-induced Suppressor Function.  Con-A-activated T  cells prolifer- 
ated after addition of TCGF, whereas nonactivated control cells did not, indicating 
that Con-A-activated cells are susceptible to further stimulation by this factor (Table 
I),  possibly by  expressing  receptors  for  TCGF.  The  suppressor  activity of Con-A- 
activated  cells  was  expressed  as  a  reduced  degree  of proliferation  induced  in  the 
responding cells by the addition of PHA or the exposure to allogeneic lymphocytes 
and a  decreased number of immunoglobulin-secreting cells induced by PWM  (Table 
II). Addition of TCGF to the second cultures (indicator systems) resulted in abrogation 
of the suppressor activity, as determined by both induction of DNA synthesis and of 
immunoglobulin  synthesis  (Table II). It seemed possible that  Con-A-activated sup- 1362  PALACIOS AND Mt~LLER  BRIEF DEFINITIVE REPORT 
TABLE I 
Response to TCGF of Con-A-activated Peripheral Blood T Cells 
Dilutions of TCGF* 
Cells 
1:2  1:4  1:8 
Nonactivated T  1.1 ~: 0.1§  1.0 ±  0.3  0.8 3= 0.2 
Con-A-activated T  10.7 ±  1.5  6.5 3= 0.8  4.9 3= 1.1 
Con-A-activated T  +  CYA~  1.9 ±  0.4  1.3 ±  0.5  1.1 ±  0.4 
* TCGF obtained  from PHA-stimulated MNC  (see text)  was diluted  in CCM  and incubated with  104  cells/well of 
nonactivated T  cells  or Con-A-activated T  cells  for 48 h  at  37°C, proliferation was determined by measuring [nH]- 
thymidine uptake during the last 12 h of culture. 
CYA (1/~g/ml) was added together with Con-A to T cells (see text). 
§ cpm ×  10  -s, mean ±  SD of four separate experiments, each in triplicate. 
TABLE II 
Effect of TCGF on the Con-A-induced Suppressor T Cell Function 
Percent suppression 
TCGF dilu-  [SH]thymidine uptake  Cell assay  tion* 
Ig synthesis 
PHA:~  MLR~: 
Con-A-activated T  --  57.0 3= 2.2  60.8 3= 4.1  5&2 3= 3.8 
Con-A-activated T  1:2  -3.7 3= 2.5  --4.9 ±  3.8  12.7 3= 4.1 
Con-A-activated T  1:4  -1.1 ±  0.9  -0.8 :t:  1.3  20.9 3= 4.4 
* TCGF  diluted in CCM was added to cell cultures to obtain final dilutions (1:2 and 1:4), 
:~ Indicator systems, PHA and alloantigen MLR-induced DNA synthesis  and PWM-induced immunoglobulin production. 
Mean ±  SD of four independent experiments, each in triplicate. 
pressor  cells  exerted  their  function  by  absorbing  TCGF,  thereby  depriving  the 
responding cells of the necessary growth factors. 
Con-A-activated T  Cells Exert Suppression by Absorbing Out TCGF.  The ability of TCGF 
to abrogate T  cell suppression could then be a result of binding of TCGF to specific 
receptors expressed in Con-A-activated T  cells. To test this hypothesis, Con-A-acti- 
vated suppressor T  cells were preincubated with TCGF (final dilution  1:2) for 4  h at 
37°C. The cells were washed and their suppressor activity tested as described above. 
The supernates resulting from the incubation of Con-A-activated cells with TCGF 
were tested for TCGF activity as  described before. We also studied  whether these 
supernates would still have the capacity to inhibit the Con-A-induced suppressor cell 
function. One out of three independent experiments is shown in Tables III and IV. It 
was found that incubation of Con-A activated suppressor cells with TCGF resulted in 
a loss of their capacity to suppress both PHA- and alloantigen-induced DNA synthesis, 
whereas activated suppressor cells preincubated in medium instead of  TCGF possessed 
suppressor activity. On the other hand, the TCGF-supernates that had been added to 
Con-A-activated cells and  subsequently recovered showed a  significant decrease in 
their capacity to  abrogate suppressor  activity exerted by Con-A-activated T  cells. 
They also lost their capacity to maintain proliferation of activated T  cells (Tables III 
and  IV).  Thus,  it seems  likely that  Con-A-induced  suppressor T  cells function by 
removing TCGF that bind to specific receptors expressed only in activated T  cells. 
The ability of TCGF to abrogate suppressor cells would be achieved by saturating the 
TCGF-binding receptors on the activated suppressor cells. 
Experiments were carried out in the presence of a constant concentration of TCGF 
(final dilution 1:2) but with increasing numbers of Con-A-activated T  cells added to 
PHA-induced DNA synthesis (indicator system). It was found that there was a close PALACIOS  AND  MOLLER  BRIEF  DEFINITIVE  REPORT  1363 
TABLE  III 
Effect of TCGF on Con-A-induced Suppressor Cell Function 
Cell assays 
PHA-in- 
duced [SH]- 
thymidine 
uptake 
MNC 
MNC +  PHA 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
MNC +  PHA + 
nonactivated T 
Con-A-activated T 
C,  on-A- and CYA-treated T* 
Con-A-activated T  +  TCGF:~ 
COn-A- and CYA-treated T  +  TGGF* 
Con-A-activated T  (preincubated with TGGI0§ 
Con-A- and CYA-treated T  (preincubated with TGGF)* 
nonactivated T  (preincubated with TGGF)§ 
Con-A-activated T  +  TGGF (preincubated with Con-A-activated T)§ 
Con-A-activated T  +  TCGF (preincubated with Gon-A and CYA-treated T)* 
Con-A-activated T  (preincubated with TGGF) +  TCGF§ 
MNC +  PHA +  COn-A- and CYA- treated T  (preincubated with TCGI0* +  TCGF 
MNC +  PHA + Con-A-activated  T  (preincubated with TCGF) + TCGF (preincubated Con-A-activated 
T) 
MNC +  PHA + TCGF~ 
MNC +  PHA +  Con-A-activated T  +  TCGF (added 48 h before end of cuhure) 
cprn  ×  10 -n 
2.2 
130.4 
139.4 
67.3 
124.1 
191.5 
206.9 
157.0 
148.4 
141.6 
73.5 
188.6 
210.7 
231.4 
165.1 
215.0 
111.9 
* CYA (1 #g/ml) together with Gon-A was added to T cells to activate suppressor cells. 
TCGF added at final dilution  1:2. 
§ Con-A-activated T  (preincubated with TGGF), Con-A-activated T  cells incubated with TCGF for 4 h  at 37°C before 
their addition to the second culture (see text). TCGF (preincubated with Con-A-activated T), supernates resulting from 
the preincubation of Con-A-activated T  cells with TCGF. 
TAI~LE IV 
Effect of TCGF on Con-A-induced Suppressor Cell Function 
Cell assays 
MLR-in- 
duced 
[nH]thymi- 
dine uptake 
A* 
A+B* 
A +  B +  nonactivated T 
A +  B +  Con-A-activated T 
A  +  B  +  Con-A- and CYA-treated T 
A +  B +  Con-A-activated T  +  TCGF 
A +  B +  Con-A- and CYA-treated T  +  TCGF 
A +  B +  Con-A-activated T  (preincubated with TCGF) 
A +  B +  COn-A- and CYA-treated T  (preincubated with TCGF) 
A +  B +  Con-A-activated T  (preincubated with TCGF) +  TCGF 
A +  B +  Con-A- and CYA-treated T  (preincubated with TCGF) +  TCGF 
A +  B +  Con-A-activated T  +  TCGF (preincubated with Con-A-activated T) 
A +  B +  Con-A-activated T  +  TCGF (preincubated with Con-A- and CYA-treated T) 
A +  B +  TCGF~ 
A +  B +  TCGF (preincubated with Con-A-activated T) 
A +  B +  TCGF (preincubated with Con-A- and CYA-treated T) 
A  +  B  +  Gon-A-activated T  (preincubated with TCGF) +  TCGF (preincubated with Con-A-activated 
13 
A +  B +  Con-A- and CYA-treated T  (preincubated with TCGF) +  TCGF (preincubated with Con-A-  227.9 
and CYA-treated T) 
A +  B +  Con-A-activated T  +  TCGF (added 906 h before end of culture)  121.3 
A  +  B  +  Con-A-activated T  +  TCGF (added 48 h before end of culture)  80.6 
cpm  ×  10 -s 
1.1 
78.4 
81.7 
31.6 
76.9 
188.4 
236.0 
84.1 
89.9 
235.6 
245.3 
36.3 
228.7 
241.0 
56.8 
233.1 
82.5 
* A, responding cells; B, stimulator cells (irradiated). 
:~ TCGF final dilution  1:2. Con-A-activated cells preincubated with TCGF, Con-A-activated cells that were preincubated 
with TGGF (4 h, 37°C) and added to the second culture. TCGF preincubated with Con-A-activated cells, supemates 
resulting from the preincubation of Con-A-activated cells with TCGF; CYA, I ~tg/ml CYA together with Con-A were 
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TABLE  V 
Effect of CYA on Con-A-induced Suppressor Cell Function 
Percent suppression 
Cells  TCGF*  [aH]thymidine uptake 
addition 
PHA  MRL 
Ig synthesis 
Con-A-activated T 
Con-A-activated T  +  1 #g/ml CYA 
Con-A-activated T  +  3 #g/ml CYA 
Con-A-activated T  +  1 #g/ml CYA  1:2 
62.0 ±  3.5:~  60.7  +  4.2  54.2 3= 3.6 
4.4:1:1.1  3.8:t:  1.3  7.5± 1.9 
1.2 ±  0.5  1.8 ±  0.4  5.4 ±  2.1 
-9.3 ±  1.6  -10.1 +  2.2  1.8 +  0.7 
* TCGF was added together with Con-A- and CYA-treated T  cells to the second culture (indicator system). 
Mean ±  SD of three separate experiments. 
§ CYA together with Con-A were added to peripheral blood T cells to induce suppressor cells. 
correlation between the number of Con-A activated T  cells added and the ability of 
TCGF to abrogate suppressor cell function. Thus, the capacity of TCGF to abrogate 
suppressor cell activity decreased with increasing numbers of Con-A-activated cells 
added to the indicator system (data not shown). 
CYA Abrogates Con-A-induced Suppressor Function.  CYA seems to inhibit the expression 
of receptors for TCGF in T  ceils, as previously suggested by ourselves (9,  10) and by 
Larsson (11). Accordingly, it was found that CYA effectively inhibited the induction 
of suppressor T  ceils by Con-A, whereas the Con-A-activated T  cells not exposed to 
CYA were suppressive (Table V). Moreover, the addition of CYA together with Con- 
A to T  cells made these ceils unresponsive to TCGF (Table I) and unable to absorb 
the growth factor (Tables III and IV). 
Discussion 
The results presented here show that Con-A-activated suppressor T  cells respond to 
TCGF stimulation, and that TCGF abrogates the suppressor activity exerted by these 
cells on the proliferation of MNC induced by PHA or alloantigens and on induction 
of immunoglobulin production driven by PWM. 
The most probable mechanism by which TCGF inhibits T  cell suppression appears 
to be by saturating TCGF-specific receptors expressed in the membrane of Con-A- 
activated T cells, because these cells absorbed TCGF and thereafter lost their capacity 
to suppress. The supernates obtained after incubation of TCGF with Con-A-activated 
cells lost TCGF activity as well as the capacity to inhibit Con-A-induced suppression. 
Moreover, by increasing the number of  Con-A-activated T cells added to the indicator 
system, it was possible to revert the capacity of TCGF to abrogate Con-A suppressor 
function. Altogether these findings support the notion that Con-A-activated suppressor 
T cells absorb TCGF and that one mechanism by which these cells exert their function 
is by decreasing the  availability of TCGF elaborated during the  activation of the 
responding cells in the indicator system. 
Any procedure that inhibits or blocks the expression of TCGF receptors in T  cells 
or cause a decreased production or availability of this growth factor would impair the 
proliferation and growth of activated T cells. CYA inhibits the expression of receptors 
for TCGF, but does not have any effect once these receptors have been expressed (9, 
10).  Thus,  addition  of CYA  together  with  Con-A  to  T  cells  makes  these  cells 
unresponsive to TCGF and unable to absorb the growth factor and abrogates their 
capacity to exert suppression. PALACIIOS AND MOLLER  BRIEF DEFINITIVE REPORT  1365 
Summary 
Concanavalin A  (Con-A)-induced  suppressor T  cells were found to respond to T 
cell growth factor (TCGF) by proliferation. TCGF abrogated the suppressor activity 
exerted by these cells on phytohemagglutinin  (PHA)- and alloantigen-induced  lym- 
phocyte  proliferation  and  on  pokeweed  mitogen  (PWM)-driven  immunoglobulin 
secretion.  The  Con-A-activated  suppressor  T  cells  absorbed  the  TCGF  activity, 
preincubation of these active suppressor cells with TCGF abolished their suppressor 
activity and addition of increasing numbers of Con-A-activated T  cells reverted the 
abrogator,/ effect of TCGF.  Altogether,  these  findings  suggest  that  Con-A-induced 
suppressor T  cells exert their function  by decreasing the available levels of TCGF. 
Cyclosporin-A (CYA), which is known to inhibit the expression of receptors for TCGF 
on  T  cells,  also  inhibited  the  suppressor  activity  as  determined  in  both  indicator 
systems,  namely  PHA-  or  alloantigen-induced  DNA  synthesis  and  PWM-induced 
immunoglobulin synthesis. CYA made Con-A-treated T  cells unresponsive to TCGF 
and unable to absorb the growth factor, supporting the notion that CYA inhibits the 
expression of TCGF receptors on T  cells, a  mechanism by which this drug seems to 
abrogate Con-A-induced suppressor T  cell function. 
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